Embryonal Neoplasm — Trials

Embryonal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 101–150 of 423 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03213665	Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)	completed	Phase 2	20	National Cancer Institute (NCI)NIH	2	Apr 13, 2026	clinicaltrials
NCT05407441	Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors	active not recruiting	Phase 1 / Phase 2	49	Susan Chi, MDOTHER	1	Apr 13, 2026